Výsledky vyhledávání - Michael G. Natchus
- Zobrazuji výsledky 1 - 17 z 17
-
1
-
2
-
3
β- <scp>d</scp> - <i>N</i> <sup>4</sup> -Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome Autor Nadya Urakova, Valeriya Kuznetsova, David K. Crossman, Arpine Sokratian, David B. Guthrie, Alexander A. Kolykhalov, Mark A. Lockwood, Michael G. Natchus, Michael R. Crowley, George R. Painter, Elena I. Frolova, Ilya Frolov
Vydáno 2017Artigo -
4
Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors Autor Michael J. Janusz, E.B. Hookfin, S.A. Heitmeyer, J. Frederick Woessner, Anthony J. Freemont, Judith A. Hoyland, Kimberly K. Brown, Lily C. Hsieh, Neil G. Almstead, B De, Michael G. Natchus, S. PIKUL, Yetunde O. Taiwo
Vydáno 2001Artigo -
5
An Orally Available, Small-Molecule Polymerase Inhibitor Shows Efficacy Against a Lethal Morbillivirus Infection in a Large Animal Model Autor Stefanie A. Krumm, Dan Yan, Elise S. Hovingh, Taylor J. Evers, Theresa Enkirch, G. Prabhakar Reddy, Aiming Sun, Manohar Saindane, Richard F. Arrendale, George R. Painter, Dennis C. Liotta, Michael G. Natchus, Veronika von Messling, Richard K. Plemper
Vydáno 2014Artigo -
6
4′-Fluorouridine inhibits alphavirus replication and infection <i>in vitro</i> and <i>in vivo</i> Autor Peiqi Yin, Nicholas May, Laura Sandra Lello, Atef Fayed, M. Guston Parks, Adam M. Drobish, Sainan Wang, Meghan K. Andrews, Zachary M. Sticher, Alexander A. Kolykhalov, Michael G. Natchus, George R. Painter, Andres Merits, Margaret Kielian, Thomas E. Morrison
Vydáno 2024Artigo -
7
The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection Autor George R. Painter, Richard A. Bowen, Gregory R. Bluemling, John DeBergh, Vindhya Edpuganti, Prabhakar R. Gruddanti, David B. Guthrie, Michael Hager, Damien L. Kuiper, Mark A. Lockwood, Deborah G. Mitchell, Michael G. Natchus, Zachary M. Sticher, Alexander A. Kolykhalov
Vydáno 2019Artigo -
8
4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication Autor Julien Sourimant, Carolin M. Lieber, Megha Aggarwal, Robert M. Cox, Josef D. Wolf, Jeong-Joong Yoon, Märt Toots, Chengjin Ye, Zachary M. Sticher, Alexander A. Kolykhalov, Luis Martínez‐Sobrido, Gregory R. Bluemling, Michael G. Natchus, George R. Painter, Richard K. Plemper
Vydáno 2022Artigo -
9
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model Autor Carolin M. Lieber, Robert M. Cox, Julien Sourimant, Josef D. Wolf, Kate B. Juergens, Quynh Phung, Manohar Saindane, Meghan K. Smith, Zachary M. Sticher, Alexander A. Kalykhalov, Michael G. Natchus, George R. Painter, Kaori Sakamoto, Alexander L. Greninger, Richard K. Plemper
Vydáno 2022Artigo -
10
Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists Autor Valarie M. Truax, Huanyu Zhao, Brooke M. Katzman, Anthony R. Prosser, Ana A. Alcaraz, Manohar Saindane, Randy B. Howard, Deborah G. Culver, Richard F. Arrendale, Prahbakar R. Gruddanti, Taylor J. Evers, Michael G. Natchus, James P. Snyder, Dennis C. Liotta, Lawrence J. Wilson
Vydáno 2013Artigo -
11
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models Autor Robert M. Cox, Carolin M. Lieber, Josef D. Wolf, Amir-Hossein Karimi, Nicole A. P. Lieberman, Zachary M. Sticher, Pavitra Roychoudhury, Meghan K. Andrews, Rebecca E. Krueger, Michael G. Natchus, George R. Painter, Alexander A. Kolykhalov, Alexander L. Greninger, Richard K. Plemper
Vydáno 2023Artigo -
12
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia Autor Märt Toots, Jeong-Joong Yoon, Robert M. Cox, M. N. Hart, Zachary M. Sticher, Negar Makhsous, Roland Plesker, Alec H. Barrena, Prabhakar Reddy, Deborah G. Mitchell, Ryan C. Shean, Gregory R. Bluemling, Alexander A. Kolykhalov, Alexander L. Greninger, Michael G. Natchus, George R. Painter, Richard K. Plemper
Vydáno 2019Artigo -
13
4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses Autor Carolin M. Lieber, Megha Aggarwal, Jeong-Joong Yoon, Robert M. Cox, Hae-Ji Kang, Julien Sourimant, Märt Toots, Scott K. Johnson, Cheryl A. Jones, Zachary M. Sticher, Alexander A. Kolykhalov, Manohar Saindane, S. Mark Tompkins, Oliver Planz, George R. Painter, Michael G. Natchus, Kaori Sakamoto, Richard K. Plemper
Vydáno 2023Artigo -
14
Modeling Heartland virus disease in mice and therapeutic intervention with 4′-fluorouridine Autor Jonna B. Westover, Kie Hoon Jung, Cigdem Alkan, Kirsten M. Boardman, Arnaud J. Van Wettere, Craig Martens, Inioska Rojas, Philip Hicks, Aaron J. Thomas, Manohar Saindane, Gregory R. Bluemling, Shuli Mao, Alexander A. Kolykhalov, Michael G. Natchus, Paul Bates, George R. Painter, Tetsuro Ikegami, Brian B. Gowen
Vydáno 2024Artigo -
15
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses Autor Jeong-Joong Yoon, Märt Toots, Sujin Lee, Myungeun Lee, Barbara Ludeke, Jasmina M. Luczo, Ketaki Ganti, Robert M. Cox, Zachary M. Sticher, Vindya Edpuganti, Deborah G. Mitchell, Mark A. Lockwood, Alexander A. Kolykhalov, Alexander L. Greninger, Martin L. Moore, George R. Painter, Anice C. Lowen, S. Mark Tompkins, Rachel Fearns, Michael G. Natchus, Richard K. Plemper
Vydáno 2018Artigo -
16
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 Autor Angela Wahl, Lisa E. Gralinski, Claire Johnson, Wenbo Yao, Martina Kovářová, Kenneth H. Dinnon, Hongwei Liu, Victoria J. Madden, Halina Krzystek, Chandrav De, Kristen White, Kendra L. Gully, Alexandra Schäfer, Tanzila Zaman, Sarah R. Leist, P. Grant, Gregory R. Bluemling, Alexander A. Kolykhalov, Michael G. Natchus, Frederic B. Askin, George R. Painter, Edward P. Browne, Corbin D. Jones, Raymond J. Pickles, Ralph S. Baric, J. Víctor García
Vydáno 2021Artigo -
17
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice Autor Timothy P. Sheahan, Amy Sims, Shuntai Zhou, Rachel L. Graham, Andrea J. Pruijssers, Maria L. Agostini, Sarah R. Leist, Alexandra Schäfer, Kenneth H. Dinnon, Laura J. Stevens, James D. Chappell, Xiaotao Lu, Tia M. Hughes, Amelia S. George, Collin S Hill, Stephanie A. Montgomery, Ariane J. Brown, Gregory R. Bluemling, Michael G. Natchus, Manohar Saindane, Alexander A. Kolykhalov, George R. Painter, Jennifer L. Harcourt, Azaibi Tamin, Natalie J. Thornburg, Ronald Swanstrom, Mark R. Denison, Ralph S. Baric
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Medicine
Virology
Biology
Virus
Disease
Infectious disease (medical specialty)
Coronavirus disease 2019 (COVID-19)
Internal medicine
Pathology
Pharmacology
Genetics
Immunology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Viral replication
Alphavirus
Antiviral drug
Coronavirus
Drug
Microbiology
Pandemic
Anatomy
Endocrinology
Gene
In vivo
Influenza A virus
Respiratory system
2019-20 coronavirus outbreak
Alphavirus infection
Biochemistry
Chemistry